Arbutus Biopharma Corporation
(NASDAQ : ABUS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.26%80.040.9%$592.67m
CELGCelgene Corporation
-1.35%136.981.1%$550.87m
AMGNAmgen Inc.
-0.08%186.051.1%$449.49m
BIIBBiogen Inc.
0.22%345.231.2%$387.34m
REGNRegeneron Pharmaceuticals, Inc.
-1.30%436.832.7%$313.83m
ALNYAlnylam Pharmaceuticals, Inc
-1.94%116.4010.7%$251.34m
VRTXVertex Pharmaceuticals Incorporated
-0.38%154.471.9%$220.62m
INCYIncyte Corporation
-0.37%115.212.5%$207.20m
ALXNAlexion Pharmaceuticals, Inc.
-1.92%140.411.9%$178.54m
ILMNIllumina, Inc.
-0.23%206.013.5%$139.56m
EXELExelixis, Inc.
-1.87%27.776.5%$132.90m
CLVSClovis Oncology, Inc.
-2.42%79.3516.5%$121.66m
BLUEBluebird Bio, Inc.
-1.23%138.4817.3%$116.67m
SRPTSarepta Therapeutics, Inc.
-0.18%51.6316.9%$109.83m
BMRNBioMarin Pharmaceutical Inc.
-4.43%89.404.4%$98.91m

Company Profile

Arbutus Biopharma Corp. is a biopharmaceutical company. It focuses on discovering, developing and commercializing a cure for patients suffering from chronic HBV infection, a liver disease caused by the hepatitis B virus. The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada.